Levodopa Induced Dyskinesia (LID)
5 clinical trials · Condition
◉ Watch Levodopa Induced Dyskinesia (LID)
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia (NCT02439203) | Bukwang Pharmaceutical | 2015-05-01 |
| Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia (NCT02274766) | Adamas Pharmaceuticals, Inc. | 2014-10-01 |
| Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID (NCT02153632) | Adamas Pharmaceuticals, Inc. | 2014-07-30 |
| Open-Label Safety Study of ADS-5102 in PD Patients With LID (NCT02202551) | Adamas Pharmaceuticals, Inc. | 2014-07-01 |
| ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) (NCT02136914) | Adamas Pharmaceuticals, Inc. | 2014-05-01 |
Track Levodopa Induced Dyskinesia (LID) automatically
Every clearance here is in the API, with alerts when new ones post.